Skip to main content
. 2016 Dec 28;147(2):227–234. doi: 10.3945/jn.116.238840

TABLE 1.

Sociodemographic description of ENDO study participants by sample and quartile of total phytoestrogen concentrations1

Operative sample2
General sample3
Characteristics Overall Q1 Q2 Q3 Q4 P Overall Q1 Q2 Q3 Q4 P
n 494 123 124 124 123 131 32 33 33 33
Age, y 33 ± 7 34 ± 7 33 ± 7 31 ± 7 33 ± 7 0.03 32 ± 8 32 ± 7 34 ± 6 32 ± 9 31 ± 8 0.42
BMI, kg/m2 28 ± 8 30 ± 8 29 ± 8 27 ± 7 27 ± 7 0.03 27 ± 7 28 ± 6 27 ± 6 27 ± 8 26 ± 7 0.69
Age at menarche, y 13 ± 2 13 ± 2 13 ± 2 13 ± 2 13 ± 2 0.61 13 ± 2 13 ± 2 13 ± 1 12 ± 1 13 ± 2 0.66
Self-identified race/ethnicity 0.18 0.14
 Hispanic 68 (14) 15 (12) 11 (9) 23 (19) 19 (15) 14 (11) 4 (13) 2 (6) 6 (18) 2 (6)
 Non-Hispanic white 369 (75) 98 (80) 102 (82) 84 (68) 85 (69) 106 (82) 25 (78) 29 (88) 24 (73) 28 (85)
 Non-Hispanic black 8 (2) 0 (0) 2 (2) 2 (2) 4 (3) 2 (2) 0 (0) 0 (0) 2 (6) 0 (0)
 Asian, Pacific Islander, or American Indian 29 (6) 5 (4) 4 (3) 9 (7) 11 (9) 5 (4) 3 (9) 0 (0) 0 (0) 2 (6)
 Other or multiracial 20 (4) 5 (4) 5 (4) 6 (5) 4 (3) 4 (3) 0 (0) 2 (6) 1 (3) 1 (3)
Married or living as married 370 (76) 93 (76) 103 (83) 87 (71) 87 (73) 0.11 78 (60) 20 (63) 24 (73) 17 (52) 17 (52) 0.23
Education 0.002 0.29
 ≤High school or equivalent 98 (20) 37 (30) 24 (19) 19 (16) 18 (15) 13 (10) 6 (19) 4 (12) 1 (3) 2 (6)
 Some college or vocational school 197 (40) 47 (38) 50 (40) 60 (49) 40 (33) 58 (44) 14 (44) 16 (48) 16 (48) 12 (36)
 ≥College graduate 195 (40) 39 (32) 50 (40) 43 (35) 63 (52) 60 (46) 12 (38) 13 (39) 16 (48) 19 (58)
Household income 0.51 0.86
 Below poverty line 55 (11) 13 (11) 11 (9) 19 (15) 12 (10) 16 (12) 6 (19) 2 (6) 4 (12) 4 (12)
 Within 180% of poverty line 58 (12) 19 (16) 13 (11) 12 (10) 14 (12) 17 (13) 4 (13) 4 (13) 5 (15) 4 (12)
 Above poverty line 373 (76) 89 (74) 99 (80) 92 (75) 93 (78) 92 (75) 22 (69) 26 (81) 24 (73) 25 (76)
Multi- or prenatal vitamins taken >1 time/wk in past 3 mo 240 (49) 61 (50) 58 (47) 61 (49) 60 (49) 0.97 66 (50) 17 (53) 18 (55) 10 (30) 21 (64) 0.05
Soy products taken >1 time/wk in past 3 mo 31 (6) 4 (3) 2 (2) 6 (5) 19 (15) <0.0001 13 (10) 3 (9) 2 (6) 1 (3) 7 (21) 0.07
Physical activity 0.81 0.13
 Low 78 (18) 21 (20) 17 (15) 19 (17) 21 (19) 20 (16) 2 (7) 9 (30) 6 (18) 3 (10)
 Moderate 161 (37) 42 (40) 43 (38) 40 (37) 36 (32) 53 (43) 17 (59) 11 (37) 11 (33) 14 (45)
 High 198 (45) 41 (39) 53 (47) 50 (46) 54 (49) 50 (41) 10 (34) 10 (33) 16 (48) 14 (45)
Smoking status 0.005 0.68
 Nonsmoker 429 (87) 96 (78) 107 (86) 114 (92) 112 (91) 117 (89) 30 (94) 30 (91) 29 (88) 28 (85)
 Current (≥1 cigarette/d) 65 (13) 27 (22) 17 (14) 10 (8) 11 (9) 14 (11) 2 (6) 3 (9) 4 (12) 5 (15)
Alcohol 0.30 0.84
 None 384 (78) 95 (77) 98 (79) 102 (82) 89 (72) 100 (76) 24 (75) 27 (82) 25 (76) 24 (73)
 ≥1 drink/wk 110 (22) 28 (23) 26 (21) 22 (18) 34 (28) 31 (24) 8 (25) 6 (18) 8 (24) 9 (27)
Mean number of caffeinated beverages consumed/d 0.04 0.97
 0 96 (19) 13 (11) 32 (28) 22 (18) 29 (25) 44 (34) 10 (31) 11 (34) 10 (31) 13 (39)
 1 138 (28) 40 (34) 28 (25) 35 (29) 35 (31) 43 (33) 11 (34) 12 (38) 10 (31) 10 (30)
 ≥2 229 (46) 63 (54) 54 (47) 62 (52) 50 (44) 42 (33) 11 (34) 9 (28) 12 (38) 10 (30)
1

Values are means ± SDs or n (%). The respective operative sample concentration ranges for quartiles 1–4 were 7–435, 436–1310, 1320–3670, and 3670–184,000 nmol/L; the respective general population sample concentration ranges were 51–574, 575–1280, 1290–4490, and 4500–62,600 nmol/L. ENDO, Endometriosis, Natural History, Diagnosis, and Outcomes; Q, quartile.

2

Missing information on age (n = 1), BMI (n = 4), age at menarche (n = 1), marital status (n = 5), educational status (n = 4), income (n = 8), physical activity (n = 57), and caffeinated beverage consumption (n = 31).

3

Missing information on income (n = 1), physical activity (n = 8), and caffeinated beverage consumption (n = 2).